PWM
XBI icon

Perigon Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Perigon Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,610
Closed -$662K – 1374
2025
Q3 		$662K Sell
6,610
-110
-2% -$9.91K 0.01% 646
2025
Q2 		$557K Buy
6,720
+1,910
+40% +$152K 0.01% 639
2025
Q1 		$390K Buy
4,810
+300
+7% +$26.8K 0.01% 712
2024
Q4 		$396K Buy
4,510
+860
+24% +$83.3K 0.01% 715
2024
Q3 		$361K Buy
3,650
+400
+12% +$39.3K 0.01% 720
2024
Q2 		$301K Buy
3,250
+1,056
+48% +$94.7K 0.01% 687
2024
Q1 		$208K Sell
2,194
-3,375
-61% -$313K 0.01% 799
2023
Q4 		$497K Sell
5,569
-650
-10% -$48.3K 0.02% 501
2023
Q3 		$454K Buy
6,219
+1,521
+32% +$121K 0.02% 466
2023
Q2 		$391K Buy
4,698
+40
+0.9% +$3.35K 0.02% 523
2023
Q1 		$355K Buy
4,658
+930
+25% +$77.2K 0.02% 482
2022
Q4 		$309K Buy
+3,728
New +$302K 0.02% 520
2021
Q1 		– Sell
-804
Closed -$113K – 1047
2020
Q4 		$113K Buy
+804
New +$103K 0.01% 520

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perigon Wealth Management's XBI Position: Q4 2025 in Review

Perigon Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 6,610 shares — an estimated $662K sold.

Perigon Wealth Management first reported a position in XBI in Q4 2020 and held it in 13 quarters. The position peaked at $662K in Q3 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

  • Perigon Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
  • Perigon Wealth Management sold 6,610 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $662K.
  • Perigon Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 13 quarters.
  • Perigon Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $662K in Q3 2025.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Perigon Wealth Management's 13F filing for Q4 2025, filed 16 Jan 2026.